Sá Michel Pompeu Barros Oliveira, Carvalho Martinha Milliany Barros, Sobral Filho Dário Celestino, Cavalcanti Luiz Rafael Pereira, Diniz Roberto Gouvea Silva, Rayol Sérgio Costa, Soares Alexandre Magno Macário Nunes, Sá Frederico Browne Correia de Araujoe, Menezes Alexandre Motta, Clavel Marie-Annick, Pibarot Philippe, Lima Ricardo Carvalho
Division of Cardiovascular Surgery of Pronto Socorro Cardiológico de Pernambuco - PROCAPE, Recife, Brazil.
University of Pernambuco - UPE, Recife, Brazil.
Interact Cardiovasc Thorac Surg. 2019 Jul 1;29(1):74-82. doi: 10.1093/icvts/ivy364.
This study sought to evaluate the impact of surgical aortic root enlargement (ARE) on the perioperative outcomes of aortic valve replacement (AVR).
Databases were searched for studies published until April 2018 to carry out a systematic review followed by meta-analysis of results.
The search yielded 1468 studies for inclusion. Of these, 10 articles were analysed and their data extracted. A total of 13 174 patients (AVR with ARE: 2819 patients; AVR without ARE: 10 355 patients) were included from studies published from 2002 to 2018. The total rate of ARE was 21.4%, varying in the studies from 5.7% to 26.3%. The overall odds ratio (OR) [95% confidence interval (CI)] for perioperative mortality showed a statistically significant difference between the groups (among 10 studies), with a higher risk in the 'AVR with ARE' group (OR 1.506, 95% CI 1.209-1.875; P < 0.001), but not when adjusted for isolated AVR + ARE without any concomitant procedures such as mitral valve surgery, coronary artery bypass surgery, etc. (OR 1.625, 95% CI 0.968-2.726; P = 0.066-among 6 studies). The 'AVR with ARE' group showed an overall lower risk of significant patient-prosthesis mismatch among 9 studies (OR 0.472, 95% CI 0.295-0.756; P = 0.002) and a higher overall difference in means of indexed effective orifice area among 10 studies (random-effect model: 0.06 cm2/m2, 95% CI 0.029-0.103; P < 0.001).
Surgical ARE seems to be associated with increased perioperative mortality but with lower risk of patient-prosthesis mismatch.
本研究旨在评估主动脉根部扩大术(ARE)对主动脉瓣置换术(AVR)围手术期结局的影响。
检索数据库中截至2018年4月发表的研究,进行系统评价并对结果进行荟萃分析。
检索得到1468项纳入研究。其中,对10篇文章进行了分析并提取了数据。纳入了2002年至2018年发表的研究中的总共13174例患者(行ARE的AVR:2819例患者;未行ARE的AVR:10355例患者)。ARE的总发生率为21.4%,各研究中的发生率在5.7%至26.3%之间。围手术期死亡率的总体比值比(OR)[95%置信区间(CI)]在两组之间显示出统计学上的显著差异(在10项研究中),“行ARE的AVR”组风险更高(OR 1.506,95% CI 1.209 - 1.875;P < 0.001),但在针对单纯AVR + ARE且无二尖瓣手术、冠状动脉搭桥手术等任何伴随手术进行调整后则无差异(OR 1.625,95% CI 0.968 - 2.726;P = 0.066 - 在6项研究中)。“行ARE的AVR”组在9项研究中显示出总体较低的显著人工瓣膜 - 患者不匹配风险(OR 0.472,95% CI 0.295 - 0.756;P = 0.002),并且在10项研究中指数化有效瓣口面积均值的总体差异更大(随机效应模型:0.06 cm²/m²,95% CI 0.029 - 0.103;P < 0.001)。
主动脉根部扩大术似乎与围手术期死亡率增加相关,但人工瓣膜 - 患者不匹配风险较低。